news

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced the appointment of Paolo

WALLINGFORD, England–(BUSINESS WIRE)–Research partners from pharma, academia, and SMEs have come together to form the Reward Task Optimisation Consortium (RTOC).

Annual Sales Tracking to Exceed Previous Year Sales of $2 million SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the

Milciclib was well tolerated and no drug related deaths were reported 28 out of 31 treated patients were evaluable, with

Vedolizumab subcutaneous is currently under review for approval for ulcerative colitis with the European Medicines Agency (EMA) and U.S. Food

Blood supplies are essential for saving lives, but China’s demand for blood exceeds supply.  Detraxi, a biotechnology company, is working

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announces the closure of the

WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco

SADDLEBROOK, N.J.–(BUSINESS WIRE)–Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, today announced the U.S. launch & commercial shipment of a

OTEZLA reduced the number and pain of oral ulcers in the 12-week placebo-controlled Phase 3 RELIEF™ study With this third